MCMegmar Aparecida dos Santos Carneiro

Megmar Aparecida dos Santos Carneiro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Megmar Aparecida dos Santos Carneiro has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epidemiological dynamics and molecular characteristics of HIV-1 among transgender women in the Central-West region of Brazil

    by Bruno Vinícius Diniz e Silva, Sylvia Lopes Maia Teixeira, Paulie Marcelly Ribeiro dos Santos, Larissa Silva Magalhães, José Henrique Pilotto, Ingebourg Georg, Carlos Silva de Jesus, Rayana Katylin Mendes Da Silva, Karlla Antonieta Amorim Caetano, Robert Lewis Cook, et al.

    Introduction: The human immunodeficiency virus (HIV) epidemic disproportionately affects key populations, including transgender women (TGW). Understanding the epidemiological and molecular characteristics on HIV-1 infection among TGW in Brazil, a continental country, is important to support decisions about public health policies. Therefore, this cross-sectional study aimed to evaluate the HIV prevalence and associated risk factors, recency of infection, genetic diversity of HIV-1, transmission clusters, and drug resistance mutations among TGW in Goiás, a state in the Central-West region of Brazil. Methods: A total of 440 participants from three cities in Goiás (Goiânia, Itumbiara, and Jataí) were recruited using Respondent-Driven Sampling. Serum samples were screened for anti-HIV antibodies using rapid tests and an enzyme-linked immunosorbent assay. Recent acquisitions were identified from plasma samples using the Limiting Antigen Avidity assay. Deoxyribonucleic acid was extracted from blood samples, and the partial polymerase gene (protease/reverse transcriptase region) was amplified using a nested polymerase chain reaction. Sequences were subtyped, analyzed for potential transmission networks, and assessed for drug resistance using the Stanford HIVdb program. Results: Most participants were young, single, self-identified as Black or mixed-race, and had a secondary education level or less. Many reported early sexual debut and multiple high-risk behaviors for sexually transmitted infections. The overall prevalence was 27.3%, with 43.2% classified as recent acquisitions and 56.8% as long-standing. Being over 25 years of age and engaging in chemsex were significantly associated with infection ( p < 0.05). Regarding genetic diversity, subtype B was the most prevalent, followed by F1 and C. Ten transmission clusters were identified; each composed of at least two sequences. High prevalence of drug resistance mutations (39.1%) was observed among TGW. Conclusion: These findings underscore the high burden of HIV-1 among TGW in the Central-West region of Brazil and highlight the importance of serological and molecular surveillance in guiding targeted interventions aimed at preventing HIV acquisition and formulating well-informed public health policies for this key population.


  • Open Access

    First report on human T-lymphotropic virus 1 infection in a group of transgender women

    by Megmar Aparecida dos Santos Carneiro, Mykaella Cristina Araújo Margarida, Bruno Vinícius Diniz e Silva, Ágabo Macedo da Costa e Silva, Márcia Alves Dias de Matos, Karlla Antonieta Amorim Caetano, Sheila Araújo Teles, Antonio Carlos Rosário Vallinoto, Regina Maria Bringel Martins

    Introduction: There is a lack of data on human T-lymphotropic virus 1 (HTLV-1) infection among transgender women (TGW). Therefore, this study estimated the prevalence of HTLV-1 infection in a group of TGW in Brazil.Methods: A cross-sectional study was conducted with 235 TGW in Goiânia City, Central Brazil. Respondent-driven sampling was used for recruitment. All participants were interviewed, and serum samples were tested for anti-HTLV-1/2 using an enzyme-linked immunosorbent assay (ELISA; Murex HTLV-I + II, DiaSorin, Dartford, United Kingdom). Seropositive samples were submitted for confirmation by Western blot (WB; MP Diagnostics HTLV BLOT 2.4 test, MP Biomedicals, Germany).Results: The majority of participants were young (≤ 25 years old), self-declared mixed or brown ethnicity, single, had attended high school, and had a monthly income above US$ 255 (R$ 1,000,00; nearly the minimum wage in Brazil at the time). Most reported earlier age at first sex and various risk behaviors for sexually transmitted infections (STIs). Three TGW were anti-HTLV-1/2 positive by ELISA and were subsequently positive for HTLV-1 by WB, giving a crude HTLV-1 seroprevalence of 1.3%; 1.0% (95% CI: 0.0–1.9) after being weighted by RDS Analysis Tool (RDSAT). The HTLV-1 seropositive TGW reported high-risk sexual behaviors. In addition, one of them also engaged in injecting drug use.Conclusion: These data indicate the circulation of HTLV-1 in TGW in Goiânia City, Central Brazil. Given the alarming estimates of high-risk sexual behaviors, there is an urgent need to intensify health programs targeting this population to control and prevent HTLV-1 and other STIs effectively.


  • Open Access

    The Global Prevalence of HTLV-1 and HTLV-2 Infections among Immigrants and Refugees—A Systematic Review and Meta-Analysis

    by Thaís Augusto Marinho, Michele Tiemi Okita, Rafael Alves Guimarães, Ana Laura de Sene Amâncio Zara, Karlla Antonieta Amorim Caetano, Sheila Araújo Teles, Márcia Alves Dias de Matos, Megmar Aparecida dos Santos Carneiro, Regina Maria Bringel Martins

    This is the first systematic review and meta-analysis to estimate the prevalence of human T-lymphotropic virus 1 and 2 (HTLV-1 and 2) infections among immigrants and refugees worldwide. PubMed/MEDLINE, Scopus, EMBASE, Web of Science, and Virtual Health Library (VHL) databases were searched for studies published from their inception to 6 January 2023. A meta-analysis using a generalized linear mixed model with a random effect was performed for HTLV-1 and HTLV-2. Subgroup analyses were performed based on the decade of study, sample size, confirmatory methods, region of study, risk group, and region of origin. Of the 381 studies initially identified, 21 were included. The pooled prevalence of HTLV-1 and HTLV-2 was 1.28% (95% CI: 0.58, 2.81) and 0.11% (95% CI: 0.04, 0.33), respectively. HTLV-1 prevalence differed significantly by region of origin, with the highest prevalence among those from the Western Pacific Region (7.27%; 95% CI: 2.94, 16.83). The subgroup analysis also showed significant differences between the estimates of HTLV-1 considering the decade of study, sample size, and region of study. For HTLV-2, significant differences were shown in relation to sample size, confirmatory methods, and risk group. The higher HTLV-1 prevalence found deserves public health attention in immigrant and refugee-receiving non-endemic countries.


  • Open Access

    Hepatitis E Prevalence in Vulnerable Populations in Goiânia, Central Brazil

    by Sheila Araújo Teles, Karlla Antonieta Amorim Caetano, Megmar Aparecida dos Santos Carneiro, Livia Melo Villar, Jeanne-Marie Stacciarini, Regina Maria Bringel Martins

    A transversal study was conducted among 472 vulnerable individuals (recyclable waste pickers, immigrants and refugees, homeless individuals, as well as lesbian, gay, bisexual, and transexual individuals) in Goiânia City, the capital of the State of Goiás, Brazil, to investigate the prevalence of hepatitis E virus (HEV) infection. A total of 459 (97.2%) serum samples were tested for anti-HEV IgG and IgM antibodies using fully automated chemiluminescence immunoassays (Liaison® Murex Anti-HEV IgG and IgM assays, DiaSorin, Saluggia, Italy). Positive samples were tested for the presence of HEV RNA by a real-time polymerase chain reaction. A seroprevalence of 0.87% (95% confidence interval [CI]: 0.34–2.22) was found for anti-HEV IgG. Furthermore, anti-HEV IgM was detected in only one individual (0.22%; 95% CI: 0.04–1.22), who was also negative for HEV RNA. These findings revealed that HEV infection is infrequent in vulnerable individuals in Central Brazil, with low seroprevalence of past and recent HEV infections.


  • Human Papillomavirus Positivity at 3 Anatomical Sites Among Transgender Women in Central Brazil

    by Brunna Rodrigues Msc de Oliveira, Bruno Vinícius Msc Diniz e Silva, Kamila Cardoso Msc dos Santos, Karlla Antonieta Amorim Caetano, Giana Mota, Vera Aparecida Saddi, Sílvia Helena Rabelo-Santos, Luísa Lina Villa, Krishna PhD Vaddiparti, Robert L. Cook, et al.

    Background: Transgender women (TGW) are susceptible to the acquisition of sexually transmitted infections (STIs), including human papillomavirus (HPV). Nonetheless, the exact data for this population are scarce. We estimated HPV positivity at the anal, genital, and oral sites among TGW and also identified the related characteristics and behaviors that could be risk factors for HPV infection in a sample of TGW in Brazil. Furthermore, we characterized the site-specific HPV genotypes among those who were positive for HPV at these 3 sites. Methods: A cross-sectional study was conducted on TGW in Goiânia City (Central-Midwest region), Brazil, between April 2018 and August 2019. Respondent-driven sampling was applied for recruitment. Next, self-collected anal, genital, and oral samples were examined for HPV DNA using polymerase chain reaction (SPF-10 primer). Human papillomavirus genotypes were identified in 12 TGW. Results: In the TGW included in the study, the anal, genital, and oral HPV positivity values were 77.2% (95% confidence interval [CI], 67.3%–84.6%), 33.5% (95% CI, 26.1%–48.9%), and 10.9% (95% CI, 5.8%–17.0%), respectively. In addition, the majority of 12 participants who tested for HPV had multiple genotypes. HPV-52 was the most prevalent genotype identified at the anal (66.6%) and genital (40.0%) sites, whereas HPV-62 and HPV-66 were the most common at the oral site (25.0%). Conclusions: A high HPV positivity was observed among TGW. Therefore, additional epidemiological studies on HPV genotypes should generate health intervention information, including the prevention, diagnosis, and treatment of sexually transmitted infections.


  • Open Access

    Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study

    by Grazielle Rosa da Costa e Silva, Winny Éveny Alves Moura, Kamila Cardoso dos Santos, Davi Oliveira Gomes, Gabriela Nolasco Bandeira, Rafael Alves Guimarães, Claci Fátima Weirich Rosso, Gabriela Silvério Bazilio, Vanessa Rafaela Milhomem Cruz Leite, Karlla Antonieta Amorim Caetano, et al.

    The coronavirus disease 2019 (COVID-19) pandemic has changed the course of human history and killed millions of people worldwide. Its long-term consequences remain uncertain. This study aimed to describe the short- and long-term symptoms of COVID-19 among individuals in Goiás, central Brazil, who experienced acute mild or non-symptomatic SARS-CoV-2 infection during the first wave of the pandemic. This prospective cohort study included 110 healthcare workers, 18 safety workers, and 19 administrative support workers, who were followed up for 12 months after the onset of COVID-19. Most participants were healthy adult female healthcare professionals. At the onset of infection, the major symptoms were headache, myalgia, nasal congestion, cough, coryza, anosmia, ageusia, sore throat, fatigue, diarrhea, and dyspnea. Furthermore, 20.3% of the participants had three or more COVID-19 symptoms that persisted for at least 12 months. These included coryza, congestion, hair loss, sore throat, headache, myalgia, cough, memory loss, anosmia, and fatigue. This study revealed a high prevalence of persistent symptoms of COVID-19 in healthy individuals from central Brazil, which may present an additional burden on healthcare services. Further studies are required to investigate the sequelae of COVID-19 over periods greater than 12 months.


  • Open Access

    RT-LAMP Multicenter Study for SARS-CoV-2 Genome Molecular Detection in Brazilian Swab and Saliva Samples

    by Vanessa Duarte da Costa, Alanna Calheiros Santos, Lucas Lima da Silva, Wilian Jean Wiggers, Claudia Alexandra Pontes Ivantes, Danielle Malta Lima, Jeová Keny Baima Colares, Deusilene Souza Vieira Dallacqua, Ana Rita Coimbra Motta-Castro, Alberto Martín Rivera Dávila, et al.

    Reverse transcription loop-mediated isothermal amplification (RT-LAMP) is a rapid method that can replace RT-qPCR. A simple molecular assay for SARS-CoV-2 RNA detection in gold-standard diagnosis through swabs and alternative specimens such as saliva could be helpful in promoting genomic surveillance. A multicenter study was conducted to evaluate the RT-LAMP assay method as an alternative for the molecular detection of SARS-CoV-2 lineages in swab and saliva samples. A total of 350 swabs from individuals with (n = 276) or without (n = 74) COVID-19 tested by RT-qPCR were collected. Paired saliva was also collected from 90 individuals who had SARS-CoV-2 RNA that was detectable (n = 30) or undetectable (n = 60) via RT-qPCR. For the RT-LAMP methodology, six primers were used for ORF1 gene amplification. As for SARS-CoV-2 genotyping, 39 swabs had the whole genome sequenced by MinION. The sensitivity of RT-LAMP to the swab was 90.2%. For the swab samples with Ct ≤ 30, the sensitivity improved by 96%. Considering saliva with Ct ≤ 30 in RT-qPCR testing, the RT-LAMP sensitivity was 100%. The RT-LAMP specificity was 100% for both the swab and saliva samples. This RT-LAMP assay was capable of detecting all the SARS-CoV-2 lineages circulating in the Brazilian swab samples. The RT-LAMP method has significant potential for use in clinical routines since it was capable of detecting SARS-CoV-2 RNA in swab and saliva samples.


  • Herpes, Syphilis, and Human Immunodeficiency Virus Coinfection Among Transgender Women in Central Brazil

    by Bruno Vinícius Msc Diniz e Silva, Juliana Burgo Msc Godoi Alves, Brunna Rodrigues Msc de Oliveira, Ana Livia Bsc Santos Sousa, Mykaella Cristina Araújo Msc Margarida, Paulie Marcelly Ribeiro dos Santos, Flávia Freitas Msc de Oliveira Bonfim, Vanessa Salete de Paula, Livia Melo Villar, Karla Antonieta Amorim Caetano, et al.

    Background: Human herpesvirus 2 (HSV-2) is a major cause of sexually transmitted infections (STIs) worldwide and often occurs synergistically with syphilis, and human immunodeficiency virus (HIV) infection. Transgender women (TGW) are disproportionately affected by STIs. The aim of this study was to estimate the prevalence of HSV-2 monoinfection, and HSV-2, syphilis, and HIV coinfection (triple infection) among TGW in Central Brazil. Methods: A seroprevalence survey was conducted among TGW in Central Brazil from 2018 to 2019. Participants were recruited using respondent-driven sampling and interviewed about their sociodemographic characteristics and STI risk behaviors, and were tested for antibodies to HSV-2, Treponema pallidum, and HIV. Multivariable logistic regression models were used to identify variables associated with HSV-2 monoinfection and triple infection. Results: Of the 431 participants, 345 (80%) were positive for HSV-2 antibodies, of whom 36 were HSV-2 immunoglobulin M–positive, and 340 were HSV-2 immunoglobulin G–positive. Human herpesvirus 2 and HIV coinfection, HIV and syphilis coinfection, and triple infection were detected in 38 participants (9.0%), 58 participants (13.8%), and 27 participants (6.4%), respectively. Report of a previous STI was associated with a decreased risk of HSV-2 monoinfection (adjusted odds ratio, 0.39), and an increased risk of triple infection (adjusted odds ratio, 4.4). Participants who reported sex not only with men had a 2.42-fold increased risk of triple infection. Conclusions: The high prevalence of HSV-2, syphilis, and HIV coinfection among TGW is a cause for concern. Transgender women should be screened for HIV and other STIs. Further studies of risk factors for triple infection among TGW are warranted.

  • Open Access

    Hepatitis B and C in Immigrants and Refugees in Central Brazil: Prevalence, Associated Factors, and Immunization

    by Thaynara Lorrane Silva Martins, Grazielle Rosa da Costa e Silva, Carla de Almeida Silva, Davi Oliveira Gomes, Bruno Vinícius Diniz e Silva, Megmar Aparecida dos Santos Carneiro, Leonora Rezende Pacheco, Natalia Motta de Araujo, Margareth Santos Zanchetta, Sheila Araujo Teles, et al.

    Introduction: Eliminating hepatitis B and C in immigrant and refugee populations is a significant challenge worldwide. Given the lack of information in Brazil, this study aimed to estimate the prevalence of infections caused by hepatitis B and C viruses and factors associated with hepatitis B in immigrants and refugees residing in central Brazil. Methods: An observational, cross-sectional, and analytical study was conducted from July 2019 to January 2020 with 365 immigrants and refugees. Hepatitis B was detected by a rapid immunochromatographic test, enzyme immunoassay, and chemiluminescence, and hepatitis C by rapid immunochromatographic test. Multiple analysis was used to assess factors associated with hepatitis B infection. Results: Of the participants, 57.8% were from Haiti and 35.6% were from Venezuela. Most had been in Brazil for less than 2 years (71.2%). The prevalence of HBV infection and exposure was 6.6% (95% CI: 4.5–9.6%) and 27.9% (95% CI: 23.6–2.8%), respectively, and 34% had isolated anti-HBs positivity. Reporting a sexually transmitted infection was statistically associated with HBV infection (OR: 7.8; 95% CI: 2.3–26.4). No participant with positive anti-HCV serology was found. Conclusions: The study showed that participants were outside the reach of prevention and control actions for hepatitis B. Therefore, public health strategies must be designed to reach, inform, and vaccinate this group.